AQR Capital Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

AQR Capital Management’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-74,927	Closed	-$187K	–	2400
2023 Q2	$187K	Sell	74,927 -202,179	-73%	-$552K	﹤0.01%	2085
2023 Q1	$743K	Buy	+277,106	New	+$1.33M	﹤0.01%	1641
2019 Q4	–	Sell	-21,188	Closed	-$483K	–	2196
2019 Q3	$483K	Buy	+21,188	New	+$668K	﹤0.01%	1767
2019 Q2	–	Sell	-19,447	Closed	-$323K	–	2206
2019 Q1	$323K	Sell	19,447 -13,028	-40%	-$247K	﹤0.01%	1949
2018 Q4	$622K	Buy	32,475 +13,424	+70%	+$503K	﹤0.01%	1683
2018 Q3	$996K	Buy	19,051 +8,381	+79%	+$457K	﹤0.01%	1710
2018 Q2	$464K	Buy	+10,670	New	+$457K	﹤0.01%	2002

Other funds holding GTHX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

AQR Capital Management's GTHX Position: Q3 2023 in Review

AQR Capital Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2023, closing a stake of 74,927 shares — an estimated $187K sold.

AQR Capital Management first reported a position in GTHX in Q2 2018 and held it in 7 quarters. The position peaked at $996K in Q3 2018. 72 funds tracked by Wall St. Rank hold GTHX as of Q3 2023.

AQR Capital Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
AQR Capital Management sold 74,927 G1 Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $187K.
AQR Capital Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2018 and held it in 7 quarters.
AQR Capital Management's G1 Therapeutics, Inc. Common Stock position peaked at $996K in Q3 2018.
72 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2023.

Based on AQR Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.